Impact BioMedical Inc. (IBO)Healthcare | Biotechnology | Houston, United States | NYSE American
0.65 USD
-0.02
(-2.730%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.64 0.00 (0.000%) ⇩ (April 17, 2026, 7:50 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★★★☆☆ |
Hot Take | April 18, 2026, 10:23 p.m. EDT
High-risk speculative catalyst driven by merger announcement, but fundamentally compromised by severe liquidity crisis (cash reserves of $3k vs market cap of ~$69m) and formal 'going concern' audit warning. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.141723 |
| AutoETS | 0.143465 |
| AutoARIMA | 0.144416 |
| AutoTheta | 0.192209 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 36.66 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.148 |
| Excess Kurtosis | -1.03 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.001 |
| Market Cap | 69,544,696 |
| Website | https://www.impactbiomedinc.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.53571427 |
| Address1 | 1,400 Broadfield Blvd. |
| Address2 | Suite 130 |
| All Time High | 6.17 |
| All Time Low | 0.362 |
| Ask | 0.6571 |
| Ask Size | 100 |
| Average Daily Volume10 Day | 158,150 |
| Average Daily Volume3 Month | 4,367,570 |
| Average Volume | 4,367,570 |
| Average Volume10Days | 158,150 |
| Bid | 0.6203 |
| Bid Size | 100 |
| Book Value | 0.121 |
| City | Houston |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.645 |
| Current Ratio | 0.354 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.6599 |
| Day Low | 0.612 |
| Display Name | Impact BioMedical |
| Ebitda | -3,125,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -23.196 |
| Enterprise To Revenue | 2,265.24 |
| Enterprise Value | 72,487,696 |
| Eps Trailing Twelve Months | -0.38 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.54464 |
| Fifty Day Average Change | 0.10035998 |
| Fifty Day Average Change Percent | 0.18426846 |
| Fifty Two Week Change Percent | 53.571426 |
| Fifty Two Week High | 1.95 |
| Fifty Two Week High Change | -1.3050001 |
| Fifty Two Week High Change Percent | -0.66923076 |
| Fifty Two Week Low | 0.362 |
| Fifty Two Week Low Change | 0.283 |
| Fifty Two Week Low Change Percent | 0.78176796 |
| Fifty Two Week Range | 0.362 - 1.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,726,493,400,000 |
| Float Shares | 106,674,013 |
| Free Cashflow | -1,520,375 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -392,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.89018995 |
| Held Percent Institutions | 0.013350001 |
| Implied Shares Outstanding | 107,821,231 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc |
| Long Name | Impact BioMedical Inc. |
| Market | us_market |
| Market Cap | 69,544,696 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_644355879 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -11,838,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 69,544,693 |
| Open | 0.6 |
| Operating Cashflow | -1,890,000 |
| Operating Margins | -165.42857 |
| Payout Ratio | 0.0 |
| Phone | 281 415 6576 |
| Post Market Change | -0.00040000677 |
| Post Market Change Percent | -0.062016554 |
| Post Market Price | 0.6446 |
| Post Market Time | 1,776,469,819 |
| Previous Close | 0.6631 |
| Price Hint | 4 |
| Price To Book | 5.3305783 |
| Price To Sales Trailing12 Months | 2,173.2717 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.007 |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0181 |
| Regular Market Change Percent | -2.72961 |
| Regular Market Day High | 0.6599 |
| Regular Market Day Low | 0.612 |
| Regular Market Day Range | 0.612 - 0.6599 |
| Regular Market Open | 0.6 |
| Regular Market Previous Close | 0.6631 |
| Regular Market Price | 0.645 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 106,579 |
| Return On Assets | -0.1416 |
| Return On Equity | -1.04159 |
| Revenue Per Share | 0.001 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 107,821,231 |
| Shares Percent Shares Out | 0.0178 |
| Shares Short | 1,915,023 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 152,299 |
| Short Name | Impact BioMedical, Inc. |
| Short Percent Of Float | 0.16309999 |
| Short Ratio | 0.19 |
| Source Interval | 15 |
| State | TX |
| Symbol | IBO |
| Total Cash | 3,000 |
| Total Cash Per Share | 0.0 |
| Total Debt | 0 |
| Total Revenue | 32,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.38 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.56027 |
| Two Hundred Day Average Change | 0.08472997 |
| Two Hundred Day Average Change Percent | 0.1512306 |
| Type Disp | Equity |
| Volume | 106,579 |
| Website | https://www.impactbiomedinc.com |
| Zip | 77,084 |